MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Sells 2,162 Shares of Oscar Health, Inc. (NYSE:OSCR)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. decreased its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 1.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 206,771 shares of the company’s stock after selling 2,162 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Oscar Health were worth $2,779,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the business. JPMorgan Chase & Co. grew its holdings in shares of Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock valued at $139,246,000 after purchasing an additional 8,051,379 shares during the last quarter. BIT Capital GmbH grew its stake in shares of Oscar Health by 5,711.6% during the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock worth $60,129,000 after buying an additional 4,396,872 shares during the last quarter. Deerfield Management Company L.P. Series C grew its stake in shares of Oscar Health by 50.7% during the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock worth $159,062,000 after buying an additional 3,983,325 shares during the last quarter. Gilder Gagnon Howe & Co. LLC increased its holdings in shares of Oscar Health by 51.4% during the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock worth $85,154,000 after buying an additional 2,151,256 shares in the last quarter. Finally, Clearbridge Investments LLC bought a new position in shares of Oscar Health in the 4th quarter valued at $19,088,000. Institutional investors own 75.70% of the company’s stock.

Insiders Place Their Bets

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the transaction, the director now directly owns 64,512 shares of the company’s stock, valued at $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 24.39% of the company’s stock.

Oscar Health Price Performance

OSCR opened at $16.42 on Wednesday. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79. The firm’s fifty day moving average price is $13.58 and its two-hundred day moving average price is $14.64. The company has a market capitalization of $4.11 billion, a price-to-earnings ratio of -820.59 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR) last posted its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $0.09. The business had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The company’s quarterly revenue was up 42.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.62 EPS. As a group, analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Wells Fargo & Company lowered Oscar Health from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, two have issued a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Oscar Health has a consensus rating of “Hold” and an average target price of $20.08.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.